Clinical Trial Update: Efficacy of Daily IV Administration of Dornase Alfa Up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence At 6 Months [Phase 2]

View source ↗

Summary

Phase 2 trial assessing whether daily IV dornase alfa given within 14 days after subarachnoid hemorrhage improves functional independence at 6 months.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Cerebral Ischemia
• Intracranial Aneurysm
• Subarachnoid Hemorrhage

Drugs mentioned

• Pulmozyme (dornase alfa)

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Ruptured Aneurysm of Intracranial Artery, SAH (Subarachnoid Hemorrhage) | Phase 2 | Status: NOT_YET_RECRUITING